OPEN Foundation

Search
Close this search box.

[Off-label ketamine treatment for treatment-resistant depression: win-win?]

Share This Post

Smith-Apeldoorn, S. Y., Veraart, J. K. E., & Schoevers, R. A. (2019). Off-label ketamine treatment for treatment-resistant depression: win-win?., https://europepmc.org/abstract/med/31512733
Link to full text

OPEN Foundation

Join ICPR 2022 Online!

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. Get your ICPR 2022 livestream ticket today and use the code OPENLIVE30 at checkout for a €30 discount.

Learn More

INTERESTED IN PSYCHEDELIC RESEARCH AND THERAPIES?

Subscribe to our new OPEN-Minded newsletter to stay in the loop, hear about our events, and become a part of a community dedicated to advancing psychedelics.

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.

16 July - NDE's and Psychedelic Experiences: Commonalities & Insights

X